Precision Biosciences (DTIL) Other Operating Expenses (2022 - 2026)

Precision Biosciences (DTIL) has 5 years of Other Operating Expenses data on file, last reported at $4000.0 in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $4000.0, up 144.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$408000.0 (down 7.37% YoY), and the FY2025 annual result was -$421000.0, up 3.44% from the prior year.
• Other Operating Expenses rose to $4000.0 in Q1 2026 per DTIL's latest filing, from -$390000.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $72000.0 in Q2 2023 and troughed at -$524000.0 in Q4 2023.
• A 5-year average of -$84000.0 and a median of -$15000.0 in 2022 frame the typical range for Other Operating Expenses.
• On a YoY basis, Other Operating Expenses climbed as much as 253.19% in 2023 and fell as far as 2657.89% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at -$19000.0 in 2022, then sank by 2657.89% to -$524000.0 in 2023, then soared by 65.27% to -$182000.0 in 2024, then sank by 114.29% to -$390000.0 in 2025, then soared by 101.03% to $4000.0 in 2026.
• Business Quant data shows DTIL's Other Operating Expenses at $4000.0 in Q1 2026, -$390000.0 in Q4 2025, and $3000.0 in Q3 2025.